Business Description
Bausch Health Companies Inc
NAICS : 325412
SIC : 3741
ISIN : CA0717341071
Compare
Compare
Traded in other countries / regions
BHC.CanadaBHC.USABVF.GermanyBHC.MexicoVRX.Switzerland0QYW.UK IPO Date
2014-09-26Description
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.03 | |||||
| Equity-to-Asset | -0.04 | |||||
| Debt-to-Equity | -18.32 | |||||
| Debt-to-EBITDA | 8.1 | |||||
| Interest Coverage | 1.24 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 0.11 | |||||
| Beneish M-Score | -2.62 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 3.6 | |||||
| 3-Year EBITDA Growth Rate | -2.6 | |||||
| 3-Year EPS without NRI Growth Rate | -53.2 | |||||
| 3-Year FCF Growth Rate | -1.2 | |||||
| Future 3-5Y Total Revenue Growth Rate | 7.3 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 9.05 | |||||
| 9-Day RSI | 11.54 | |||||
| 14-Day RSI | 20.37 | |||||
| 6-1 Month Momentum % | 74.08 | |||||
| 12-1 Month Momentum % | 29.15 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.19 | |||||
| Quick Ratio | 0.82 | |||||
| Cash Ratio | 0.16 | |||||
| Days Inventory | 204.11 | |||||
| Days Sales Outstanding | 78.5 | |||||
| Days Payable | 83.93 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.9 | |||||
| Shareholder Yield % | -29.24 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 70.87 | |||||
| Operating Margin % | 18.49 | |||||
| Net Margin % | -1.87 | |||||
| FCF Margin % | 10.8 | |||||
| ROA % | -0.66 | |||||
| ROIC % | 33.44 | |||||
| ROC (Joel Greenblatt) % | 56.91 | |||||
| ROCE % | 6.07 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 1.64 | |||||
| PE Ratio without NRI | 20.47 | |||||
| Price-to-Owner-Earnings | 3.63 | |||||
| PEG Ratio | 0.62 | |||||
| PS Ratio | 0.3 | |||||
| Price-to-Free-Cash-Flow | 2.79 | |||||
| Price-to-Operating-Cash-Flow | 2.04 | |||||
| EV-to-EBIT | 18.9 | |||||
| EV-to-Forward-EBIT | 12.69 | |||||
| EV-to-EBITDA | 9.73 | |||||
| EV-to-Forward-EBITDA | 6.38 | |||||
| EV-to-Revenue | 2.73 | |||||
| EV-to-Forward-Revenue | 2.37 | |||||
| EV-to-FCF | 25.54 | |||||
| Price-to-Projected-FCF | 0.52 | |||||
| Price-to-Median-PS-Value | 0.36 | |||||
| Price-to-Peter-Lynch-Fair-Value | 3.32 | |||||
| Earnings Yield (Greenblatt) % | 5.29 | |||||
| FCF Yield % | 34.44 | |||||
| Forward Rate of Return (Yacktman) % | 27.31 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bausch Health Companies Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil MXN) | 170,412.662 | ||
| EPS (TTM) (MXN) | -8.703 | ||
| Beta | 0.11 | ||
| Volatility % | 82.62 | ||
| 14-Day RSI | 20.37 | ||
| 14-Day ATR (MXN) | 2.973051 | ||
| 20-Day SMA (MXN) | 181.5175 | ||
| 12-1 Month Momentum % | 29.15 | ||
| 52-Week Range (MXN) | 108.01 - 200.19 | ||
| Shares Outstanding (Mil) | 367.8 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bausch Health Companies Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bausch Health Companies Inc Stock Events
| Event | Date | Price(MXN) | ||
|---|---|---|---|---|
| No Event Data | ||||
Bausch Health Companies Inc Frequently Asked Questions
What is Bausch Health Companies Inc(MEX:BHC)'s stock price today?
The current price of MEX:BHC is MXN150.72. The 52 week high of MEX:BHC is MXN200.19 and 52 week low is MXN108.01.
When is next earnings date of Bausch Health Companies Inc(MEX:BHC)?
The next earnings date of Bausch Health Companies Inc(MEX:BHC) is 2025-02-21 Est..
Does Bausch Health Companies Inc(MEX:BHC) pay dividends? If so, how much?
Bausch Health Companies Inc(MEX:BHC) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers